You are here: Home » Budget » News
Business Standard

Bharat Biotech hails Rs 35,000 cr budget allocation for Covid vaccination

The indigenous Covid-19 vaccine Covaxin and Oxford's Covishield are being produced in the country

Bharat Biotech | Budget 2021 | Union Budget

Press Trust of India  |  Hyderabad 

The Rs 64,180 crore spending plan for healthcare over the next six years to be spent on primary, secondary and tertiary healthcare

Covaxin maker on

Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the and said it would help the country become free of the viral disease.

Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with "something in it for everyone".

Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Chairman and Managing Director Krishna Ella said "Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22."

The Finance Minister's commitment providing more funds in order to contain the pandemic and provide an effective, smooth path for the vaccination scheme "will help contain, and lead our nation towards accomplishing a COVID-19 disease free Bharat," he said in statement here.

The indigenous COVID-19 vaccine Covaxin and Oxford's Covishield are being produced in the country and used during the ongoing inoculation drive.

The Rs 64,180 crore spending plan for healthcare over the next six years to be spent on primary, secondary and tertiary healthcare, in addition to the National Health Mission was also a welcome move, he said.

This would strengthen public health services as 17,000 rural and 11,000 urban health and wellness centres and integrated public health labs would be set up in each district, Ellasaid.

The government focus, on three areas - preventive health, curative health and well-being, was also very reassuring, he said.

"With this landmark budget, the Government of India has signalled its intention to make health a cornerstone of the future success of our country. The allocation to vaccines signals a shift to preventive health care, a validation of the fact that vaccines are the most cost effective health care interventions, he added.

Chairman of Dr Reddy's K Satish Reddy said the government has taken a big step on healthcare, making an outlay of 2.23 lakh crores, a 137 per cent increase from last year, a step that was "long overdue".

"On innovation and R&D (Research and Development), the additional allocation of Rs 50,000 crore over five years through the National Research Foundation marks a good beginning in improving the research eco-system in the country, he opined.

As with all budgets, this too contained concrete proposals that were encouraging but it was the execution that finally matters, he said, expressing hope this time the government gets it right.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, February 01 2021. 17:39 IST